InvestorsObserver is giving Codiak BioSciences Inc (CDAK) an Analyst Rating Rank of 6, meaning CDAK is ranked higher by analysts than 6% of stocks. The average price target for CDAK is $1.4 and analyst’s rate the stock as a Hold. Wall Street analysts are rating CDAK a Hold today. Find out what this means to you and get th
Loading...
Loading...
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
